Therapeutic applications of circadian rhythms for the cardiovascular system

Frontiers in Pharmacology

Volumn 6, Issue MAR, 2015, Pages

  Tsimakouridze, Elena V ^a   Alibhai, Faisal J ^a   Martino, Tami A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Biomarkers; Cardiovascular disease; Chronotherapy; Circadian; Diurnal

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE PLUS OLMESARTAN; AMLODIPINE PLUS VALSARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BISOPROLOL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; LISINOPRIL; NEBIVOLOL; OLMESARTAN; PLACEBO; PROPRANOLOL; QUINAPRIL; RAMIPRIL; SPIRAPRIL; TELMISARTAN; VALSARTAN;

ARTICLE; BEDTIME DOSAGE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CAUSE OF DEATH; CHRONOTHERAPY; CIRCADIAN RHYTHM; DOSAGE SCHEDULE COMPARISON; DRUG DOSE TITRATION; DRUG TARGETING; EVENING DOSAGE; GENOMICS; HEART INFARCTION; HEART RATE VARIABILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; METABOLOMICS; MORNING DOSAGE; NONHUMAN; PROTEOMICS; SUDDEN CARDIAC DEATH;

EID: 84926649416     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00077     Document Type: Article

References (122)

1. Acelajado, M.C., Pisoni, R., Dudenbostel, T., Oparil, S., Calhoun, D.A., and Glasser, S.P. (2012). Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients. J Am Soc Hypertens 6, 66-72. doi: 10.1016/j.jash.2011.09.001.
2. Aguilar-Arnal, L., and Sassone-Corsi, P. (2014). Chromatin landscape and circadian dynamics: Spatial and temporal organization of clock transcription. Proc Natl Acad Sci U S A. doi: 10.1073/pnas.1411264111.
3. Aire (1993). Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet 342, 821-828.
4. Alenghat, T., Meyers, K., Mullican, S.E., Leitner, K., Adeniji-Adele, A., Avila, J., Bucan, M., Ahima, R.S., Kaestner, K.H., and Lazar, M.A. (2008). Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 456, 997-1000. doi: 10.1038/nature07541.
5. Ambrosioni, E., Borghi, C., and Magnani, B. (1995). The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med 332, 80-85. doi: 10.1056/NEJM199501123320203.
6. Andrews, N.P., Gralnick, H.R., Merryman, P., Vail, M., and Quyyumi, A.A. (1996). Mechanisms underlying the morning increase in platelet aggregation: a flow cytometry study. J Am Coll Cardiol 28, 1789-1795. doi: 10.1016/S0735-1097(96)00398-1.
7. Andrews, T.C., Fenton, T., Toyosaki, N., Glasser, S.P., Young, P.M., Maccallum, G., Gibson, R.S., Shook, T.L., and Stone, P.H. (1993). Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS). Circulation 88, 92-100.
8. Angleton, P., Chandler, W.L., and Schmer, G. (1989). Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 79, 101-106.
9. Ayas, N.T., Hirsch, A.A., Laher, I., Bradley, T.D., Malhotra, A., Polotsky, V.Y., and Tasali, E. (2014). New frontiers in obstructive sleep apnoea. Clin Sci (Lond) 127, 209-216. doi: 10.1042/CS20140070.
10. Banerjee, S., Wang, Y., Solt, L.A., Griffett, K., Kazantzis, M., Amador, A., El-Gendy, B.M., Huitron-Resendiz, S., Roberts, A.J., Shin, Y., Kamenecka, T.M., and Burris, T.P. (2014). Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour. Nat Commun 5, 5759. doi: 10.1038/ncomms6759.
11. Bellet, M.M., Nakahata, Y., Boudjelal, M., Watts, E., Mossakowska, D.E., Edwards, K.A., Cervantes, M., Astarita, G., Loh, C., Ellis, J.L., Vlasuk, G.P., and Sassone-Corsi, P. (2013). Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1. Proc Natl Acad Sci U S A 110, 3333-3338. doi: 10.1073/pnas.1214266110.
12. Biomarker Definitions Working Group, N.I.O.H. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Biomarkers Definitions Working Group. Clin Pharmacol Ther 69, 89-95. doi: 10.1067/mcp.2001.113989.
13. Bonten, T.N., Saris, A., Van Oostrom, M.J., Snoep, J.D., Rosendaal, F.R., Zwaginga, J., Eikenboom, J., Van Der Meer, P.F., and Van Der Bom, J.G. (2014). Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity. A randomised cross-over trial. Thromb Haemost 112. doi: 10.1160/TH14-05-0453.
14. Bradley, T.D., and Floras, J.S. (2003). Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation 107, 1671-1678. doi: 10.1161/01.CIR.0000061757.12581.15.
15. Bradley, T.D., and Floras, J.S. (2009). Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373, 82-93. doi: 10.1016/S0140-6736(08)61622-0.
16. Bray, M.S., and Young, M.E. (2008). Diurnal variations in myocardial metabolism. Cardiovasc Res 79, 228-237. doi: 10.1093/cvr/cvn054.
17. Bremner, W.F., Sothern, R.B., Kanabrocki, E.L., Ryan, M., Mccormick, J.B., Dawson, S., Connors, E.S., Rothschild, R., Third, J.L., Vahed, S., Nemchausky, B.M., Shirazi, P., and Olwin, J.H. (2000). Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J 139, 164-173.
18. Chan, C.T., Arab, S., Carasso, S., Moravsky, G., Li, G.H., Liu, P.P., and Rakowski, H. (2012). Impact of frequent nocturnal hemodialysis on myocardial mechanics and cardiomyocyte gene expression. Circ Cardiovasc Imaging 5, 474-480. doi: 10.1161/CIRCIMAGING.111.971606.
19. Chan, C.T., Floras, J.S., Miller, J.A., Richardson, R.M., and Pierratos, A. (2002). Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61, 2235-2239. doi: 10.1046/j.1523-1755.2002.00362.x.
20. Chan, C.T., Harvey, P.J., Picton, P., Pierratos, A., Miller, J.A., and Floras, J.S. (2003). Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 42, 925-931. doi: 10.1161/01.HYP.0000097605.35343.64.
21. Chen, Z., Yoo, S.H., and Takahashi, J.S. (2013). Small molecule modifiers of circadian clocks. Cell Mol Life Sci 70, 2985-2998. doi: 10.1007/s00018-012-1207-y.
22. Clarke, J.M., Hamer, J., Shelton, J.R., Taylor, S., and Venning, G.R. (1976). The rhythm of the normal human heart. Lancet 1, 508-512.
23. Collins, A.J., Kasiske, B., Herzog, C., Chavers, B., Foley, R., Gilbertson, D., Grimm, R., Liu, J., Louis, T., Manning, W., Mcbean, M., Murray, A., St Peter, W., Xue, J., Fan, Q., Guo, H., Li, Q., Li, S., Qiu, Y., Li, S., Roberts, T., Skeans, M., Snyder, J., Solid, C., Wang, C., Weinhandl, E., Zhang, R., Arko, C., Chen, S.C., Dalleska, F., Daniels, F., Dunning, S., Ebben, J., Frazier, E., Hanzlik, C., Johnson, R., Sheets, D., Wang, X., Forrest, B., Berrini, D., Constantini, E., Everson, S., Eggers, P., and Agodoa, L. (2007). Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis 49, A6-7, S1-296. doi: 10.1053/j.ajkd.2006.11.019.
24. Cuesta, M., Cermakian, N., and Boivin, D.B. (2014). Glucocorticoids entrain molecular clock components in human peripheral cells. FASEB J. doi: 10.1096/fj.14-265686.
25. Culleton, B.F., Walsh, M., Klarenbach, S.W., Mortis, G., Scott-Douglas, N., Quinn, R.R., Tonelli, M., Donnelly, S., Friedrich, M.G., Kumar, A., Mahallati, H., Hemmelgarn, B.R., and Manns, B.J. (2007). Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 298, 1291-1299. doi: 10.1001/jama.298.11.1291.
26. Dallmann, R., Viola, A.U., Tarokh, L., Cajochen, C., and Brown, S.A. (2012). The human circadian metabolome. Proc Natl Acad Sci U S A 109, 2625-2629. doi: 10.1073/pnas.1114410109.
27. Dardente, H., and Cermakian, N. (2007). Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol Int 24, 195-213. doi: 10.1080/07420520701283693.
28. Doherty, L.S., Kiely, J.L., Swan, V., and Mcnicholas, W.T. (2005). Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127, 2076-2084. doi: 10.1378/chest.127.6.2076.
29. Dolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., Mcclory, S., Den Hond, E., Mccormack, P., Staessen, J.A., and O'brien, E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46, 156-161. doi: 10.1161/01.HYP.0000170138.56903.7a.
30. Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Garcia-Gonzalez, M., and Reiter, R.J. (2006). Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction. Am J Cardiol 97, 1162-1164.
31. Durgan, D.J., and Young, M.E. (2010). The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res 106, 647-658. doi: 10.1161/CIRCRESAHA.109.209957.
32. Eckel-Mahan, K.L., Patel, V.R., Mohney, R.P., Vignola, K.S., Baldi, P., and Sassone-Corsi, P. (2012). Coordination of the transcriptome and metabolome by the circadian clock. Proc Natl Acad Sci U S A 109, 5541-5546. doi: 10.1073/pnas.1118726109.
33. Etchegaray, J.P., Lee, C., Wade, P.A., and Reppert, S.M. (2003). Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature 421, 177-182. doi: 10.1038/nature01314.
34. Fagard, R.H., Thijs, L., Staessen, J.A., Clement, D.L., De Buyzere, M.L., and De Bacquer, D.A. (2009). Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens 23, 645-653. doi: 10.1038/jhh.2009.9.
35. Floras, J.S. (2014). Sleep apnea and cardiovascular risk. J Cardiol 63, 3-8. doi: 10.1016/j.jjcc.2013.08.009.
36. Floras, J.S., Jones, J.V., Johnston, J.A., Brooks, D.E., Hassan, M.O., and Sleight, P. (1978). Arousal and the circadian rhythm of blood pressure. Clin Sci Mol Med Suppl 4, 395s-397s.
37. Fox, K.M., and Investigators, E.U.T.O.R.O.C.E.W.P.I.S.C.a.D. (2003). Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362, 782-788.
38. Fujimura, A., Kumagai, Y., Sugimoto, K., Nakashima, H., Kajiyama, H., Ebihara, A., and Ohashi, K. (1990). Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects. Eur J Clin Pharmacol 38, 133-137.
39. Gamble, K.L., Berry, R., Frank, S.J., and Young, M.E. (2014). Circadian clock control of endocrine factors. Nat Rev Endocrinol 10, 466-475. doi: 10.1038/nrendo.2014.78.
40. Harnett, J.D., Foley, R.N., Kent, G.M., Barre, P.E., Murray, D., and Parfrey, P.S. (1995). Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47, 884-890.
41. Harnett, J.D., Kent, G.M., Barre, P.E., Taylor, R., and Parfrey, P.S. (1994). Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 4, 1486-1490.
42. Hastings, M.H., Reddy, A.B., and Maywood, E.S. (2003). A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 4, 649-661. doi: 10.1038/nrn1177.
43. Hermida, R.C., and Ayala, D.E. (2009). Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension 54, 40-46. doi: 10.1161/HYPERTENSIONAHA.109.130203.
44. Hermida, R.C., Ayala, D.E., Calvo, C., and Lopez, J.E. (2005a). Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. J Am Coll Cardiol 46, 975-983. doi: 10.1016/j.jacc.2004.08.071.
45. Hermida, R.C., Ayala, D.E., Chayan, L., Mojon, A., and Fernandez, J.R. (2009). Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int 26, 61-79. doi: 10.1080/07420520802548135.
46. Hermida, R.C., Ayala, D.E., Fernandez, J.R., and Calvo, C. (2007). Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50, 715-722. doi: 10.1161/HYPERTENSIONAHA.107.094235.
47. Hermida, R.C., Ayala, D.E., Fontao, M.J., Mojon, A., Alonso, I., and Fernandez, J.R. (2010a). Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol Int 27, 560-574. doi: 10.3109/07420528.2010.485411.
48. Hermida, R.C., Ayala, D.E., Fontao, M.J., Mojon, A., and Fernandez, J.R. (2010b). Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Chronobiol Int 27, 1287-1303. doi: 10.3109/07420528.2010.489167.
49. Hermida, R.C., Ayala, D.E., Mojon, A., Fontao, M.J., and Fernandez, J.R. (2011). Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int 28, 601-610. doi: 10.3109/07420528.2011.589935.
50. Hermida, R.C., Calvo, C., Ayala, D.E., Fernandez, J.R., Covelo, M., Mojon, A., and Lopez, J.E. (2005b). Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens 23, 1913-1922.
51. Hoshino, A., Nakamura, T., and Matsubara, H. (2010). The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy. Clin Exp Hypertens 32, 416-422. doi: 10.3109/10641961003667948.
52. Jaffe, A.S., Babuin, L., and Apple, F.S. (2006). Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 48, 1-11. doi: 10.1016/j.jacc.2006.02.056.
53. Kaneko, Y., Floras, J.S., Usui, K., Plante, J., Tkacova, R., Kubo, T., Ando, S., and Bradley, T.D. (2003). Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348, 1233-1241. doi: 10.1056/NEJMoa022479.
54. Kasai, T., and Bradley, T.D. (2011). Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol 57, 119-127. doi: 10.1016/j.jacc.2010.08.627.
55. Kasukawa, T., Sugimoto, M., Hida, A., Minami, Y., Mori, M., Honma, S., Honma, K., Mishima, K., Soga, T., and Ueda, H.R. (2012). Human blood metabolite timetable indicates internal body time. Proc Natl Acad Sci U S A 109, 15036-15041. doi: 10.1073/pnas.1207768109.
56. Katada, S., and Sassone-Corsi, P. (2010). The histone methyltransferase MLL1 permits the oscillation of circadian gene expression. Nat Struct Mol Biol 17, 1414-1421. doi: 10.1038/nsmb.1961.
57. Kober, L., Torp-Pedersen, C., Carlsen, J.E., Bagger, H., Eliasen, P., Lyngborg, K., Videbaek, J., Cole, D.S., Auclert, L., and Pauly, N.C. (1995). A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333, 1670-1676. doi: 10.1056/NEJM199512213332503.
58. Kojetin, D.J., and Burris, T.P. (2014). REV-ERB and ROR nuclear receptors as drug targets. Nat Rev Drug Discov 13, 197-216. doi: 10.1038/nrd4100.
59. Labrecque, G., and Belanger, P.M. (1991). Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacol Ther 52, 95-107.
60. Langner, B., and Lemmer, B. (1988). Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur J Clin Pharmacol 33, 619-624.
61. Lemmer, B., Winkler, H., Ohm, T., and Fink, M. (1985). Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat. Naunyn Schmiedebergs Arch Pharmacol 330, 42-49.
62. Macchiarulo, C., Pieri, R., Mitolo, D.C., and Pirrelli, A. (1999). Management of antihypertensive treatment with Lisinopril: a chronotherapeutic approach. Eur Rev Med Pharmacol Sci 3, 269-275.
63. Maisel, A.S., Bhalla, V., and Braunwald, E. (2006). Cardiac biomarkers: a contemporary status report. Nat Clin Pract Cardiovasc Med 3, 24-34. doi: 10.1038/ncpcardio0405.
64. Marin, J.M., Carrizo, S.J., Vicente, E., and Agusti, A.G. (2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365, 1046-1053. doi: 10.1016/S0140-6736(05)71141-7.
65. Martino, T., Arab, S., Straume, M., Belsham, D.D., Tata, N., Cai, F., Liu, P., Trivieri, M., Ralph, M., and Sole, M.J. (2004). Day/night rhythms in gene expression of the normal murine heart. J Mol Med 82, 256-264.
66. Martino, T.A., and Sole, M.J. (2009). Molecular time: an often overlooked dimension to cardiovascular disease. Circ Res 105, 1047-1061. doi: 10.1161/CIRCRESAHA.109.206201.
67. Martino, T.A., Tata, N., Bjarnason, G.A., Straume, M., and Sole, M.J. (2007). Diurnal protein expression in blood revealed by high throughput mass spectrometry proteomics and implications for translational medicine and body time of day. Am J Physiol Regul Integr Comp Physiol 293, R1430-1437. doi: 10.1152/ajpregu.00183.2007.
68. Martino, T.A., Tata, N., Simpson, J.A., Vanderlaan, R., Dawood, F., Kabir, M.G., Khaper, N., Cifelli, C., Podobed, P., Liu, P.P., Husain, M., Heximer, S., Backx, P.H., and Sole, M.J. (2011). The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy. J Am Coll Cardiol 57, 2020-2028. doi: 10.1016/j.jacc.2010.11.022.
69. Meng, Q.J., Maywood, E.S., Bechtold, D.A., Lu, W.Q., Li, J., Gibbs, J.E., Dupre, S.M., Chesham, J.E., Rajamohan, F., Knafels, J., Sneed, B., Zawadzke, L.E., Ohren, J.F., Walton, K.M., Wager, T.T., Hastings, M.H., and Loudon, A.S. (2010). Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes. Proc Natl Acad Sci U S A 107, 15240-15245. doi: 10.1073/pnas.1005101107.
70. Mengden, T., Battig, B., Schubert, M., Jeck, T., Weisser, B., Buddeberg, C., and Vetter, W. (1992). Comparison of casual, ambulatory and self-measured blood pressure in a study of nitrendipine vs bisoprolol. Eur J Clin Pharmacol 42, 569-575.
71. Millar-Craig, M.W., Bishop, C.N., and Raftery, E.B. (1978). Circadian variation of blood-pressure. Lancet 1, 795-797.
72. Minami, Y., Kasukawa, T., Kakazu, Y., Iigo, M., Sugimoto, M., Ikeda, S., Yasui, A., Van Der Horst, G.T., Soga, T., and Ueda, H.R. (2009). Measurement of internal body time by blood metabolomics. Proc Natl Acad Sci U S A 106, 9890-9895. doi: 10.1073/pnas.0900617106.
73. Mohawk, J.A., Green, C.B., and Takahashi, J.S. (2012). Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 35, 445-462. doi: 10.1146/annurev-neuro-060909-153128.
74. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., De Ferranti, S., Despres, J., Fullerton, H.J., Howard, V.J., Huffman, M.D., Judd, S.E., Kissela, B.M., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Liu, S., Mackey, R.H., Matchar, D.B., Mcguire, D.K., Mohler, E.R., 3rd, Moy, C.S., Muntner, P., Mussolino, M.E., Nasir, K., Neumar, R.W., Nichol, G., Palaniappan, L., Pandey, D.K., Reeves, M.J., Rodriguez, C.J., Sorlie, P.D., Stein, J., Towfighi, A., Turan, T.N., Virani, S.S., Willey, J.Z., Woo, D., Yeh, R.W., and Turner, M.B. (2014). Heart Disease and Stroke Statistics-2015 Update: A Report From the American Heart Association. Circulation. doi: 10.1161/CIR.0000000000000152.
75. Muller, J.E., Ludmer, P.L., Willich, S.N., Tofler, G.H., Aylmer, G., Klangos, I., and Stone, P.H. (1987). Circadian variation in the frequency of sudden cardiac death. Circulation 75, 131-138.
76. Muller, J.E., Stone, P.H., Turi, Z.G., Rutherford, J.D., Czeisler, C.A., Parker, C., Poole, W.K., Passamani, E., Roberts, R., Robertson, T., and Et Al. (1985). Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 313, 1315-1322.
77. Musiek, E.S., and Fitzgerald, G.A. (2013). Molecular clocks in pharmacology. Handb Exp Pharmacol, 243-260. doi: 10.1007/978-3-642-25950-0_10.
78. Nakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D., Guarente, L.P., and Sassone-Corsi, P. (2008). The NAD+-dependent deacetylase SIRT1 modulates CLOCK583 mediated chromatin remodeling and circadian control. Cell 134, 329-340. doi: 10.1016/j.cell.2008.07.002.
79. Nissen, S.E., Tuzcu, E.M., Libby, P., Thompson, P.D., Ghali, M., Garza, D., Berman, L., Shi, H., Buebendorf, E., Topol, E.J., and Investigators, C. (2004). Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 292, 2217-2225. doi: 10.1001/jama.292.18.2217.
80. Ohkubo, T., Hozawa, A., Yamaguchi, J., Kikuya, M., Ohmori, K., Michimata, M., Matsubara, M., Hashimoto, J., Hoshi, H., Araki, T., Tsuji, I., Satoh, H., Hisamichi, S., and Imai, Y. (2002). Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 20, 2183-2189.
81. Palatini, P. (1992). Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours? Am Heart J 123, 1421-1425.
82. Paschos, G.K., Baggs, J.E., Hogenesch, J.B., and Fitzgerald, G.A. (2010). The role of clock genes in pharmacology. Annu Rev Pharmacol Toxicol 50, 187-214. doi: 10.1146/annurev.pharmtox.010909.105621.
83. Paschos, G.K., and Fitzgerald, G.A. (2010). Circadian clocks and vascular function. Circ Res 106, 833-841. doi: 10.1161/CIRCRESAHA.109.211706.
84. Paschos, G.K., Ibrahim, S., Song, W.L., Kunieda, T., Grant, G., Reyes, T.M., Bradfield, C.A., Vaughan, C.H., Eiden, M., Masoodi, M., Griffin, J.L., Wang, F., Lawson, J.A., and Fitzgerald, G.A. (2012). Obesity in mice with adipocyte-specific deletion of clock component Arntl. Nat Med 18, 1768-1777. doi: 10.1038/nm.2979.
85. Patel, V.R., Eckel-Mahan, K., Sassone-Corsi, P., and Baldi, P. (2012). CircadiOmics: integrating circadian genomics, transcriptomics, proteomics and metabolomics. Nat Methods 9, 772-773. doi: 10.1038/nmeth.2111.
86. Pfeffer, M.A., Braunwald, E., Moye, L.A., Basta, L., Brown, E.J., Jr., Cuddy, T.E., Davis, B.R., Geltman, E.M., Goldman, S., Flaker, G.C., and Et Al. (1992). Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327, 669-677. doi: 10.1056/NEJM199209033271001.
87. Pierratos, A., Ouwendyk, M., Francoeur, R., Vas, S., Raj, D.S., Ecclestone, A.M., Langos, V., and Uldall, R. (1998). Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 9, 859-868.
88. Pilorz, V., Cunningham, P.S., Jackson, A., West, A.C., Wager, T.T., Loudon, A.S., and Bechtold, D.A. (2014). A novel mechanism controlling resetting speed of the circadian clock to environmental stimuli. Curr Biol 24, 766-773. doi: 10.1016/j.cub.2014.02.027.
89. Pinotti, M., Bertolucci, C., Portaluppi, F., Colognesi, I., Frigato, E., Foa, A., and Bernardi, F. (2005). Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler Thromb Vasc Biol 25, 646-649. doi: 10.1161/01.ATV.0000153140.13148.e0.
90. Pletcher, M.J., and Pignone, M. (2011). Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact. Circulation 123, 1116-1124. doi: 10.1161/CIRCULATIONAHA.110.943860.
91. Podobed, P., Pyle, W.G., Ackloo, S., Alibhai, F.J., Tsimakouridze, E.V., Ratcliffe, W.F., Mackay, A., Simpson, J.A., Wright, D.C., Kirby, G., Young, M.E., and Martino, T.A. (2014). The Day/Night Proteome in the Murine Heart. Am J Physiol Regul Integr Comp Physiol. doi: 10.1152/ajpregu.00011.2014.
92. Podobed, P.S., Kirby, G.M., and Martino, T.A. (2012). "Circadian Proteomics and Its Unique Advantage for Discovery of Biomarkers of Heart Disease. In Man TK, Flores RJ (Eds) Proteomics. Human Diseases and Protein Functions. Croatia: InTech, pp. 65-88.").
93. Public Health Agency of Canada. (2009). "Tracking heart disease and stroke in Canada, 2009". ([Ottawa]: Public Health Agency of Canada).
94. Raj, D.S., Charra, B., Pierratos, A., and Work, J. (1999). In search of ideal hemodialysis: is prolonged frequent dialysis the answer? Am J Kidney Dis 34, 597-610. doi: 10.1016/S0272-6386(99)70382-3.
95. Reinberg, A.E. (1991). Concepts of circadian chronopharmacology. Ann N Y Acad Sci 618, 102-115.
96. Reisin, L.H., Pancheva, N., Berman, M., Khalameizer, V., Jafary, J., Yosefy, C., Blaer, Y., Manevich, I., Peled, R., and Scharf, S. (2004). Circadian variation of the efficacy of thrombolytic therapy in acute myocardial infarction-isn't the time ripe for cardiovascular chronotherapy? Angiology 55, 257-263.
97. Ridker, P.M., Manson, J.E., Buring, J.E., Muller, J.E., and Hennekens, C.H. (1990). Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation 82, 897-902.
98. Roenneberg, T., and Merrow, M. (2005). Circadian clocks - the fall and rise of physiology. Nat Rev Mol Cell Biol 6, 965-971. doi: 10.1038/nrm1766.
99. Scheer, F.A., Michelson, A.D., Frelinger, A.L., 3rd, Evoniuk, H., Kelly, E.E., Mccarthy, M., Doamekpor, L.A., Barnard, M.R., and Shea, S.A. (2011). The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors. PLoS One 6, e24549. doi: 10.1371/journal.pone.0024549.
100. Scheer, F.A., and Shea, S.A. (2013). Human circadian system causes morning peak in pro-thrombotic plasminogen activator inhibitor-1 (PAI-1) independent of sleep/wake cycle. Blood. doi: 10.1182/blood-2013-07-517060.
101. Schoenhard, J.A., Smith, L.H., Painter, C.A., Eren, M., Johnson, C.H., and Vaughan, D.E. (2003). Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2. J Mol Cell Cardiol 35, 473-481.
102. Smolensky, M.H., and D'alonzo, G.E. (1988). Biologic rhythms and medicine. Am J Med 85, 34-46.
103. Smolensky, M.H., and Peppas, N.A. (2007). Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev 59, 828-851. doi: 10.1016/j.addr.2007.07.001.
104. Sole, M.J., and Martino, T.A. (2009). Diurnal physiology: core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hypertrophy and failure. J Appl Physiol 107, 1318-1327. doi: 10.1152/japplphysiol.00426.2009.
105. Solt, L.A., Wang, Y., Banerjee, S., Hughes, T., Kojetin, D.J., Lundasen, T., Shin, Y., Liu, J., Cameron, M.D., Noel, R., Yoo, S.H., Takahashi, J.S., Butler, A.A., Kamenecka, T.M., and Burris, T.P. (2012). Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 485, 62-68. doi: 10.1038/nature11030.
106. Somers, V.K., White, D.P., Amin, R., Abraham, W.T., Costa, F., Culebras, A., Daniels, S., Floras, J.S., Hunt, C.E., Olson, L.J., Pickering, T.G., Russell, R., Woo, M., and Young, T. (2008). Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52, 686-717. doi: 10.1016/j.jacc.2008.05.002.
107. Storch, K.F., Lipan, O., Leykin, I., Viswanathan, N., Davis, F.C., Wong, W.H., and Weitz, C.J. (2002). Extensive and divergent circadian gene expression in liver and heart. Nature 417, 78-83.
108. Takeda, N., Maemura, K., Horie, S., Oishi, K., Imai, Y., Harada, T., Saito, T., Shiga, T., Amiya, E., Manabe, I., Ishida, N., and Nagai, R. (2007). Thrombomodulin is a clock-controlled gene in vascular endothelial cells. J Biol Chem 282, 32561-32567. doi: 10.1074/jbc.M705692200.
109. Townsend, N., Williams, J., Bhatnagar, P., Wickramasinghe, K., and Rayner, M.S. (2014). Cardiovascular disease statistics, 2014. British Heart Foundation, Greater London House.
110. Tsimakouridze, E.V., Straume, M., Podobed, P.S., Chin, H., Lamarre, J., Johnson, R., Antenos, M., Kirby, G.M., Mackay, A., Huether, P., Simpson, J.A., Sole, M., Gadal, G., and Martino, T.A. (2012). Chronomics of pressure overload-induced cardiac hypertrophy in mice reveals altered day/night gene expression and biomarkers of heart disease. Chronobiol Int 29, 810-821. doi: 10.3109/07420528.2012.691145.
111. Turek, F.W., Joshu, C., Kohsaka, A., Lin, E., Ivanova, G., Mcdearmon, E., Laposky, A., Losee-Olson, S., Easton, A., Jensen, D.R., Eckel, R.H., Takahashi, J.S., and Bass, J. (2005). Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308, 1043-1045. doi: 10.1126/science.1108750.
112. Ueda, H.R., Chen, W., Minami, Y., Honma, S., Honma, K., Iino, M., and Hashimoto, S. (2004). Molecular-timetable methods for detection of body time and rhythm disorders from single-time-point genome-wide expression profiles. Proc Natl Acad Sci U S A 101, 11227-11232.
113. Verdecchia, P., Schillaci, G., Guerrieri, M., Gatteschi, C., Benemio, G., Boldrini, F., and Porcellati, C. (1990). Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81, 528-536.
114. Vollmers, C., Schmitz, R.J., Nathanson, J., Yeo, G., Ecker, J.R., and Panda, S. (2012). Circadian oscillations of protein-coding and regulatory RNAs in a highly dynamic mammalian liver epigenome. Cell Metab 16, 833-845. doi: 10.1016/j.cmet.2012.11.004.
115. Walton, K.M., Fisher, K., Rubitski, D., Marconi, M., Meng, Q.J., Sladek, M., Adams, J., Bass, M., Chandrasekaran, R., Butler, T., Griffor, M., Rajamohan, F., Serpa, M., Chen, Y., Claffey, M., Hastings, M., Loudon, A., Maywood, E., Ohren, J., Doran, A., and Wager, T.T. (2009). Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period. J Pharmacol Exp Ther 330, 430-439. doi: 10.1124/jpet.109.151415.
116. Westgate, E.J., Cheng, Y., Reilly, D.F., Price, T.S., Walisser, J.A., Bradfield, C.A., and Fitzgerald, G.A. (2008). Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation 117, 2087-2095. doi: 10.1161/CIRCULATIONAHA.107.739227.
117. Witte, K., Weisser, K., Neubeck, M., Mutschler, E., Lehmann, K., Hopf, R., and Lemmer, B. (1993). Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 54, 177-186.
118. Woldt, E., Sebti, Y., Solt, L.A., Duhem, C., Lancel, S., Eeckhoute, J., Hesselink, M.K., Paquet, C., Delhaye, S., Shin, Y., Kamenecka, T.M., Schaart, G., Lefebvre, P., Neviere, R., Burris, T.P., Schrauwen, P., Staels, B., and Duez, H. (2013). Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat Med 19, 1039-1046. doi: 10.1038/nm.3213.
119. World Health Organization [Who] (2011). "Description of the global burden of NCDs, their risk factors and determinants", in: Global status report on noncommunicable diseases 2010. (Available via http://www.who.int/nmh/publications/ncd_report2010/en/).
120. Young, M.E. (2006). The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. Am J Physiol Heart Circ Physiol 290, H1-16.
121. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., and Dagenais, G. (2000). Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342, 145-153. doi: 10.1056/NEJM200001203420301.
122. Zhang, R., Lahens, N.F., Ballance, H.I., Hughes, M.E., and Hogenesch, J.B. (2014). A circadian gene expression atlas in mammals: Implications for biology and medicine. Proc Natl Acad Sci U S A. doi: 10.1073/pnas.1408886111.